東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Dermato-oncology study guide = essen...

Liu, Vincent.

FindBook

Google Book

Amazon

博客來

Dermato-oncology study guide = essential text and review /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Dermato-oncology study guide/ edited by Vincent Liu.
其他題名:	essential text and review /
其他作者:	Liu, Vincent.
出版者:	Cham :Springer International Publishing : : 2021.,
面頁冊數:	x, 389 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	Skin - Cancer. -
電子資源:	https://doi.org/10.1007/978-3-030-53437-0
ISBN:	9783030534370

Dermato-oncology study guide = essential text and review /
Dermato-oncology study guideessential text and review /[electronic resource] :edited by Vincent Liu. - Cham :Springer International Publishing :2021. - x, 389 p. :ill., digital ;24 cm.

This book provides clinicians, clinicians-in-training and researchers with a unique rapid-access educational resource on the spectrum of issues at the intersection of skin and malignancy. In it, there is clinical detail provided on how the skin reveals systemic malignancy via cutaneous metastases, genodermatoses or paraneoplastic dermatoses. At the same time, it reviews pharmacologic treatment of internal malignancy and how this can result in cutaneous adverse reactions; conversely, therapeutics for skin conditions can increase risk for internal malignancy. As arguably the most significant cutaneous malignancy, melanoma receives specific attention for its metastatic potential, current diagnostic advances, and recent therapeutic breakthroughs. Dermato-Oncology Study Guide: Essential Text and Review serves a critical educational need for clinicians caring for patients with systemic malignancy by creating an easy-to-use resource that provides practical tools to recognize skin signs of internal malignancy. Furthermore it helps in anticipating and managing adverse reactions of therapeutics for systemic malignancy, and gives the reader the opportunity to weigh the risks of malignancy of pharmacologic agents for skin disease.

ISBN: 9783030534370

Standard No.: 10.1007/978-3-030-53437-0doiSubjects--Topical Terms:

927988
Skin
--Cancer.

LC Class. No.: RC280.S5 / D47 2021

Dewey Class. No.: 616.99477

Dermato-oncology study guide = essential text and review /
LDR:02194nmm a2200313 a 4500 001 2239369
003 DE-He213
005 20210323023617.0
006 m d
007 cr nn 008maaau
008 211111s2021 sz s 0 eng d
020 $a 9783030534370 $q (electronic bk.)
020 $a 9783030534363 $q (paper)
024 7 $a 10.1007/978-3-030-53437-0 $2 doi
035 $a 978-3-030-53437-0
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.S5 $b D47 2021
072 7 $a MJK $2 bicssc
072 7 $a MED017000 $2 bisacsh
072 7 $a MJK $2 thema
082 0 4 $a 616.99477 $2 23
090 $a RC280.S5 $b D435 2021
245 0 0 $a Dermato-oncology study guide $h [electronic resource] : $b essential text and review / $c edited by Vincent Liu.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a x, 389 p. : $b ill., digital ; $c 24 cm.
520 $a This book provides clinicians, clinicians-in-training and researchers with a unique rapid-access educational resource on the spectrum of issues at the intersection of skin and malignancy. In it, there is clinical detail provided on how the skin reveals systemic malignancy via cutaneous metastases, genodermatoses or paraneoplastic dermatoses. At the same time, it reviews pharmacologic treatment of internal malignancy and how this can result in cutaneous adverse reactions; conversely, therapeutics for skin conditions can increase risk for internal malignancy. As arguably the most significant cutaneous malignancy, melanoma receives specific attention for its metastatic potential, current diagnostic advances, and recent therapeutic breakthroughs. Dermato-Oncology Study Guide: Essential Text and Review serves a critical educational need for clinicians caring for patients with systemic malignancy by creating an easy-to-use resource that provides practical tools to recognize skin signs of internal malignancy. Furthermore it helps in anticipating and managing adverse reactions of therapeutics for systemic malignancy, and gives the reader the opportunity to weigh the risks of malignancy of pharmacologic agents for skin disease.
650 0 $a Skin $x Cancer. $3 927988
650 0 $a Cancer $x Treatment $x Complications. $3 1244610
650 0 $a Cutaneous manifestations of general diseases. $3 1002049
650 1 4 $a Dermatology. $3 829009
650 2 4 $a Oncology. $3 751006
650 2 4 $a Pharmacotherapy. $3 1978501
650 2 4 $a Pharmaceutical Sciences/Technology. $3 1001579
700 1 $a Liu, Vincent. $3 811674
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-030-53437-0
950 $a Medicine (SpringerNature-11650)